Riverhead Capital Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-38,712
Closed -$3.07M 1510
2016
Q2
$3.07M Sell
38,712
-95,606
-71% -$6.82M 0.1% 251
2016
Q1
$7.39M Buy
134,318
+53,534
+66% +$2.92M 0.1% 246
2015
Q4
$4.99M Buy
80,784
+27,154
+51% +$1.71M 0.07% 333
2015
Q3
$3.38M Sell
53,630
-632
-1% -$45.1K 0.05% 371
2015
Q2
$3.96M Sell
54,262
-1,102
-2% -$79.6K 0.06% 367
2015
Q1
$3.62M Sell
55,364
-87,188
-61% -$5.8M 0.05% 374
2014
Q4
$9.27M Sell
142,552
-48,559
-25% -$3.13M 0.14% 211
2014
Q3
$11.5M Buy
191,111
+38,271
+25% +$2.5M 0.2% 152
2014
Q2
$10.6M Buy
152,840
+27,094
+22% +$1.76M 0.2% 147
2014
Q1
$8.22M Buy
125,746
+23,832
+23% +$1.55M 0.18% 159
2013
Q4
$6.31M Buy
101,914
+38,680
+61% +$2.24M 0.17% 175
2013
Q3
$3.39M Buy
63,234
+17,707
+39% +$912K 0.11% 227
2013
Q2
$2.08M Buy
+45,527
New +$1.97M 0.07% 272

Other funds holding STJ

Riverhead Capital Management's STJ Position: Q3 2016 in Review

Riverhead Capital Management sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 38,712 shares — an estimated $3.07M sold.

Riverhead Capital Management first reported a position in STJ in Q2 2013 and held it in 13 quarters. The position peaked at $11.5M in Q3 2014. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Riverhead Capital Management reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Riverhead Capital Management sold 38,712 St Jude Medical shares in Q3 2016, an estimated $3.07M.
  • Riverhead Capital Management first reported a position in St Jude Medical in Q2 2013 and held it in 13 quarters.
  • Riverhead Capital Management's St Jude Medical position peaked at $11.5M in Q3 2014.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Riverhead Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.